Substance use disorders: realizing the promise of pharmacogenomics and personalized medicine.
paper
Cited
Public
Unavailable
- Authors
- Hutchison, Kent E
- Year
- 2010
- Journal
- Annual review of clinical psychology
- PMID
- 20192794
- DOI
- 10.1146/annurev.clinpsy.121208.131441
Current pharmacological and psychosocial approaches to the treatment of alcohol dependence may best be described as modestly effective, and it is unlikely that a magic bullet for the treatment of any substance use disorder will ever be developed. Rather, it seems more likely that there will be a number of treatment options, each of which will target different mechanisms. Thus, future treatment gains are likely to depend on the ability to match individuals with the treatment most likely to benefit them, which in turn is contingent on our ability to understand the mechanisms that drive the maintenance of substance use disorders on an individual level. On a more global scale, this type of effort has been described as "personalized medicine" and has focused largely on the human genome as a source of information that can be used to match individuals to treatments. This review enumerates barriers to realizing the potential of personalized medicine for substance use disorders and identifies opportunities to overcome those barriers, which involve the development of translational approaches that focus on the development of brain-based phenotypes that serve as the target of both treatment development and of genetic research.
No figures extracted from this document.
No chunks — full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| The genetic epidemiology of substance use disorder: A review. | 2017 | 28938182 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Selective ablation of VIP interneurons in the rodent prefrontal cortex results in increased impulsivity. | Hatter JA et al. | — | 2023 | → |
| Who responds to a multi-component treatment for cannabis use disorder? Using multivariable and machine learning models to classify treatment responders and non-responders. | Tomko RL et al. | — | 2023 | → |
| Association of Drug Cues and Craving With Drug Use and Relapse: A Systematic Review and Meta-analysis. | Vafaie N et al. | — | 2022 | → |
| DRD2 methylation is associated with executive control network connectivity and severity of alcohol problems among a sample of polysubstance users. | Hagerty SL et al. | — | 2020 | → |
| Four Actionable Bottlenecks and Potential Solutions to Translating Psychiatric Genetics Research: An Expert Review. | Bourdon JL et al. | — | 2020 | → |
| A dual process perspective on advances in cognitive science and alcohol use disorder. | Lindgren KP et al. | — | 2019 | → |
| A Randomized Trial of Combined tDCS Over Right Inferior Frontal Cortex and Cognitive Bias Modification: Null Effects on Drinking and Alcohol Approach Bias. | Claus ED et al. | — | 2019 | → |
| Application of Research Domain Criteria to childhood and adolescent impulsive and addictive disorders: Implications for treatment. | Yip SW et al. | — | 2018 | → |
| A Randomized, Placebo-controlled, Clinical Trial of Prazosin for the Treatment of Alcohol Use Disorder. | Wilcox CE et al. | — | 2018 | → |
| Pharmacogenetic Effects of Naltrexone in Individuals of East Asian Descent: Human Laboratory Findings from a Randomized Trial. | Ray LA et al. | — | 2018 | → |
| Effects of varenicline on alcohol self-administration and craving in drinkers with depressive symptoms. | Roberts W et al. | — | 2017 | → |
| The genetic epidemiology of substance use disorder: A review. | Prom-Wormley EC et al. | — | 2017 | → |
| Adolescent psychotherapy for addiction medicine: From brain development to neurocognitive treatment mechanisms. | Thayer RE et al. | — | 2016 | → |
| Evaluating the Hispanic Paradox in the Context of Adolescent Risky Sexual Behavior: The Role of Parent Monitoring. | Karoly HC et al. | — | 2016 | → |
| Personalizing substance use treatment based on pre-treatment impulsivity and sensation seeking: A review. | Tomko RL et al. | — | 2016 | → |
| Brief report: cognitive control helps explain comorbidity between alcohol use disorder and internalizing disorders. | Ellingson JM et al. | — | 2015 | → |
| Dose specific effects of olanzapine in the treatment of alcohol dependence. | Littlewood RA et al. | — | 2015 | → |
| Importance of construct validity in functional neuroimaging of craving. | Thayer RE et al. | — | 2015 | → |
| Maximizing Effectiveness Trials in PTSD and SUD Through Secondary Analysis: Benefits and Limitations Using the National Institute on Drug Abuse Clinical Trials Network "Women and Trauma" Study as a Case Example. | Hien DA et al. | — | 2015 | → |
| Perceptions of genetic testing and genomic medicine among drug users. | Perlman DC et al. | — | 2015 | → |
| Brain-based origins of change language: a beginning. | Feldstein Ewing SW et al. | — | 2014 | → |
| Brain proton magnetic resonance spectroscopy of alcohol use disorders. | Meyerhoff DJ | — | 2014 | → |
| Brain regions affected by impaired control modulate responses to alcohol and smoking cues. | Liu J et al. | — | 2014 | → |
| Pharmacogenetic approaches in the treatment of alcohol use disorders: addressing clinical utility and implementation thresholds. | Hendershot CS | — | 2014 | → |
| Preliminary functional MRI results from a combined stop-signal alcohol-cue task. | Karoly HC et al. | — | 2014 | → |
| White matter integrity is associated with alcohol cue reactivity in heavy drinkers. | Monnig MA et al. | — | 2014 | → |
| Working memory as a moderator of impulsivity and alcohol involvement: testing the cognitive-motivational theory of alcohol use with prospective and working memory updating data. | Ellingson JM et al. | — | 2014 | → |
| Adolescent brain development, substance use, and psychotherapeutic change. | Wetherill R et al. | — | 2013 | → |
| Are bottom-up and top-down traits in dual-systems models of risky behavior genetically distinct? | Ellingson JM et al. | — | 2013 | → |
| Effect of homozygous deletions at 22q13.1 on alcohol dependence severity and cue-elicited BOLD response in the precuneus. | Liu J et al. | — | 2013 | → |
| Functional connectivity and cannabis use in high-risk adolescents. | Houck JM et al. | — | 2013 | → |
| Impulsivity, variation in the cannabinoid receptor (CNR1) and fatty acid amide hydrolase (FAAH) genes, and marijuana-related problems. | Bidwell LC et al. | — | 2013 | → |
| Integrating brain and behavior: evaluating adolescents' response to a cannabis intervention. | Feldstein Ewing SW et al. | — | 2013 | → |
| Neuroimaging mechanisms of change in psychotherapy for addictive behaviors: emerging translational approaches that bridge biology and behavior. | Feldstein Ewing SW et al. | — | 2013 | → |
| Personalized medicine in bipolar disorder: how can we overcome the barriers to clinical translation? | Squassina A et al. | — | 2013 | → |
| Substance use disorders: a theory-driven approach to the integration of genetics and neuroimaging. | Karoly HC et al. | — | 2013 | → |
| The contributions of cognitive neuroscience and neuroimaging to understanding mechanisms of behavior change in addiction. | Morgenstern J et al. | — | 2013 | → |
| Frontal white matter integrity predictors of adult alcohol treatment outcome. | Sorg SF et al. | — | 2012 | → |
| Health behavior change: can genomics improve behavioral adherence? | McBride CM et al. | — | 2012 | → |
| Medications development to treat alcohol dependence: a vision for the next decade. | Litten RZ et al. | — | 2012 | → |
| How psychosocial alcohol interventions work: a preliminary look at what FMRI can tell us. | Feldstein Ewing SW et al. | — | 2011 | → |
| Identifying neurobiological phenotypes associated with alcohol use disorder severity. | Claus ED et al. | — | 2011 | → |
| Pharmacogenomics for the clinical nurse specialist--genetics, prescribing, and outcomes. | O'Malley P | — | 2011 | → |
| Preliminary evidence for associations of CHRM2 with substance use and disinhibition in adolescence. | Hendershot CS et al. | — | 2011 | → |
| Proposed model of the neurobiological mechanisms underlying psychosocial alcohol interventions: the example of motivational interviewing. | Feldstein Ewing SW et al. | — | 2011 | → |
| The Big Picture of Individual Differences in Physical Activity Behavior Change: A Transdisciplinary Approach. | Bryan AD et al. | — | 2011 | → |